在初级新发每日持续性头痛和慢性偏头痛的比较中使用onabotulinumtoxinA
Sanjay Cheema1,2, Susie Lagrata2, Khadija Rerhou Rantell3
1Headache and Facial Pain Group, University College London Queen Square Institute of Neurology, London, UK.
Cephalalgia : an international journal of headache
|February 10, 2025
概括
毒素A有效治疗大约三分之一的新型每日持续性头痛 (NDPH) 患者,证明了这种耐火性头痛疾病的良好的安全性.
科学领域:
- 神经学 神经学
- 头痛 医学 医学 医学
- 临床试验 临床试验
背景情况:
- 新的每日持续性头痛 (NDPH) 是一种主要的头痛疾病,往往抗治疗.
- 对于有效的NDPH治疗方法的证据基础有限.
- 这项研究调查了NDPH的OnabotulinumtoxinA,并将其与慢性偏头痛亚型进行比较.
研究的目的:
- 评估OnabotulinumtoxinA在NDPH患者中的疗效和安全性.
- 为了比较NDPH患者的治疗结果与慢性偏头痛患者的治疗结果 (有或没有每日头痛).
主要方法:
- 用前性收集的数据进行观察性研究.
- 包括患有NDPH,患有每日头痛的慢性偏头痛 (每日-CM) 和没有每日头痛的慢性偏头痛 (非每日-CM) 的患者.
- 用两个周期的OnabotulinumtoxinA进行治疗,倾向性得分与组比较相匹配.
主要成果:
- 34.5%的NDPH患者在头痛日有≥30%的改善,相当于每日CM (43.2%) 和非每日CM (51.2%).
- 在NDPH患者的头痛严重程度和HIT-6得分方面,有显著的改善.
- 两组之间没有观察到响应率的显著差异,安全性概况相似且有利.
结论:
- 在大约三分之一的NDPH患者中,onabotulinumtoxinA是一种有效的治疗选择.
- 该疗法在研究群体中显示出良好的安全性.
- 这些发现支持OnabotulinumtoxinA作为耐火NDPH的可行治疗选择.
相关概念视频
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
653
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
653
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
673
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
673
01:20Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
01:26Cholinergic Antagonists: Therapeutic Uses
704
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
704